This Lung Cancer Awareness Month find out more about one of the most common cancers in the UK population and how CCL can support with the diagnosis and treatment pathway.
Read More
This Breast Cancer Awareness Month find out more about the most common cancer in the UK population and how CCL can support with the diagnosis and treatment pathway.
Read More
Cambridge Clinical Laboratories launches our new suite of tests to support the UK prostate cancer pathway.
Read More
Cambridge Clinical Laboratories (CCL) announces today, Friday 27 August, that CCL will be the UK partner for Prostatype Genomics in bringing the Prostatype® prostate cancer gene test to the UK market.
Read More
A research study that Cambridge Clinical Laboratories contributed to has been published by Nature Journal, with both CEO Dr Tony Cooke, and Clinical Laboratory Manager, Mike Morel being cited.
Read More
Cambridge Clinical Laboratories has launched a new partnership with C-19 Direct to provide direct to consumer Covid-19 travel testing.
Read More
Cambridge Clinical Laboratories (CCL) is delighted to have successfully added its SARS-CoV-2 service (using the Primerdesign Ltd Genesig Assay) to its UKAS accreditation – ISO 15189 - the international Quality standard for medical laboratory testing.
Read More